MST1 and Cognitive impairment: MST1 knockdown or pharmacological inhibition by XMU-MP-1 ameliorates cognitive deficits and pathological changes in 5xFAD mice through YAP-independent mechanisms including decreased pro-apoptotic p53 activation [19], increased PI3K-Akt activation, and increased mitochondrial biogenesis [120].